荷兰肺转移瘤手术治疗现状:DLCA-S 登记数据分析
本研究利用荷兰肺癌外科审计(DLCA-S)2012–2017 年数据,分析 45 家医院 2090 例因肺转移瘤行肺实质切除的患者,描述当前临床实践。最常见原发肿瘤为结直肠癌(1087 例,52.0%),最常见术式为楔形切除(1477 例,70.7%),微创手术 1548 例(74.1%)。术后复杂病程 3.6%,30 天死亡率 0.7%,各院转移瘤切除占原发性肺癌切除比例差异为 3.4%–41.5%。
要点
- 肺转移瘤手术以结直肠癌来源最多,楔形切除和微创入路为主流。
- 术后复杂病程 3.6%、30 天死亡率 0.7%,低于原发肺癌切除。
- 各院转移瘤切除比例差异大(3.4%–41.5%),提示存在实践差异。
核心结论
- DLCA-S 登记分析显示,荷兰肺转移瘤手术术后不良结局发生率有限,并发症与死亡率低于原发肺癌切除。
研究设计与样本
- 基于荷兰肺癌外科审计(DLCA-S)登记数据的回顾性分析,纳入 2012–2017 年在 45 家荷兰医院行肺实质切除治疗肺转移瘤的 2090 例患者。
主要发现
- 最常见原发癌为结直肠癌(1087 例,52.0%),其次为泌尿生殖系统癌(296 例,14.2%)。
- 最常见肺实质切除方式为楔形切除(1477 例,70.7%),其次为肺叶切除(424 例,20.3%)。
- 1548 例(74.1%)采用微创方式切除,中转开胸率 3.8%。
- 1663 例(79.6%)切除单个转移灶,40 例(1.9%)切除 4 个及以上转移灶。
- 术后复杂病程 3.6%,30 天死亡率 0.7%;各院转移瘤切除占原发肺癌切除比例的范围为 3.4%–41.5%。
临床怎么用
- 肺转移瘤手术在荷兰以楔形切除和微创入路为主,围手术期风险较低,可作为 limited 肺转移患者的治疗选择参考。
局限性
- 原文未报告研究局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Surgical resection is widely employed as a potential curative treatment option for patients with limited lung metastases originating from a wide range of primary tumours. However, there are no clear national or international practice guidelines and, thereby, the risk for potential practice variation exists. This study aims to define the current practice for the surgical treatment of pulmonary metastases in the Netherlands by using data from the Dutch Lung Cancer Audit for Surgery (DLCA-S). METHODS: Data from the DLCA-S were used to analyse patients undergoing a parenchymal lung resection for the treatment of pulmonary metastases between 2012 and 2017. Volume of metastasectomies per hospital was calculated as a proportion of the volume of primary lung cancer resection. Studied outcomes were overall complications and postoperative mortality and complicated course. For the latter, both the national average and between-hospital variation were calculated. RESULTS: A total of 2090 patients, distributed over 45 Dutch hospitals, were included for analysis. The most common primary cancer was colorectal carcinoma (N = 1087, 52.0%) followed by the urogenital carcinoma (N = 296, 14.2%). The most common type of parenchymal resection was a wedge resection (N = 1477, 70.7%) followed by a lobectomy (N = 424, 20.3%). Resection was performed minimally invasively in 1548 patients (74.1%) with a conversion rate of 3.8%. Resection of a solitary metastasis was performed in 1663 patients (79.6%). In 40 patients (1.9%), 4 or more metastases were resected. A postoperative complicated course was noted in 3.6%, and the 30-day mortality rate was 0.7%. The variety between hospitals in the volume of metastasectomies in proportion to the volume of primary lung cancer resections was 3.4-41.5%. CONCLUSIONS: This analysis of the DLCA-S registry provides a unique insight into current practice on pulmonary metastasectomies in the Netherlands over a 6-year period. The rate of postoperative adverse outcome was limited, and the morbidity and mortality were lower compared to primary lung cancer resections in the DLCA-S database.
引用
- van Dorp M, Beck N, Steup WH, et al. Surgical treatment of pulmonary metastases in the Netherlands: data from the Dutch Lung Cancer Audit for Surgery. Eur J Cardiothorac Surg. 2020. PMID: 32282876. doi:10.1093/ejcts/ezaa090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。